New drug could keep stents open after stroke, reducing need for rescue therapy

NCT ID NCT06813651

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new drug called TBO-309 in 78 people having a stroke caused by a blocked artery in the neck and brain. The drug is given through a vein during standard clot-removal and stenting procedures. The goal is to see if TBO-309 can keep the stent open without causing dangerous bleeding in the brain.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ischemic stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • John Hunter Hospital

    RECRUITING

    Newcastle, New South Wales, 2305, Australia

    Contact Email: •••••@•••••

    Contact

  • Royal North Shore Hospital

    NOT_YET_RECRUITING

    St Leonards, New South Wales, 2065, Australia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact